PharmaCorp Rx Inc.
PCRX.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 955.12% | 707.46% | -23.87% | -15.95% | -5.80% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 979.50% | 712.80% | -20.91% | -13.00% | -5.80% |
|
|
|||||
| Total Current Assets | 979.50% | 712.80% | -20.91% | -13.00% | -5.80% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,168.80% | 797.97% | -20.91% | -13.00% | -5.80% |
|
|
|||||
| Total Accounts Payable | 1,094.43% | 1,690.24% | 46.71% | 186.89% | 408.33% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1,454.43% | 2,322.56% | 46.71% | 186.89% | 408.33% |
|
|
|||||
| Total Current Liabilities | 1,454.43% | 2,322.56% | 46.71% | 186.89% | 408.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4,777.70% | 7,357.32% | 46.71% | 186.89% | 408.33% |
|
|
|||||
| Common Stock & APIC | 892.96% | 613.20% | 0.16% | 3.36% | 2.36% |
| Retained Earnings | -249.89% | -151.73% | -93.72% | -91.30% | -49.76% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1,098.79% | 737.23% | -21.96% | -14.21% | -7.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,098.79% | 737.23% | -21.96% | -14.21% | -7.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,108.95% | 743.04% | -21.96% | -14.21% | -7.05% |
|
|
|||||